Screener
Myriad Genetics MYGN Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $190.7M-10.5% | $200.4M+2.3% | $209.8M-0.4% | $205.7M-3.6% | $213.1M+0.8% | ||
| $63.7M+3.9% | $62.8M+1.8% | $63M+5.5% | $61.9M-2.5% | $61.3M-4.8% | ||
| $127M-16.3% | $137.6M+2.5% | $146.8M-2.7% | $143.8M-4.0% | $151.8M+3.2% | ||
| 66.6%-4.6pp | 68.7%+0.2pp | 70%-1.7pp | 69.9%-0.3pp | 71.2%+1.7pp | ||
| $25M-2.3% | $27.1M-1.5% | $25.5M-20.8% | $28.2M-1.1% | $25.6M-5.5% | ||
| $83.1M+15.6% | $73.6M+6.4% | $68.7M-4.6% | $71M+1.6% | $71.9M-1.2% | ||
| $57.8M-13.5% | $62.2M-6.5% | $55.6M-13.1% | $67.9M-1.9% | $66.8M-7.4% | ||
| $165.9M-65.5% | $168.3M+3.1% | $152.5M-19.7% | $167.1M-1.6% | $481M+162% | ||
| -$38.9M+88.2% | -$30.7M-5.9% | -$5.7M+85.4% | -$23.3M-16.5% | -$329.2M-802% | ||
| -20.4%+134pp | -15.3%-0.5pp | -2.7%+15.8pp | -11.3%-2.0pp | -154.5%-137pp | ||
| $4.1M+173% | $4.1M+413% | $4.4M+529% | $3.8M+375% | $1.5M+87.5% | ||
| -$3.7M-164% | -$3.4M-750% | -$3.2M-3,100% | -$2.9M-142% | -$1.4M-100% | ||
| -$42.6M+87.1% | -$34.1M-16.0% | -$8.9M+77.2% | -$26.2M-23.6% | -$330.6M-789% | ||
| $600K+700% | $0+100% | -$1M-129% | $1.2M+33.3% | -$100K+80.0% | ||
| -$43.2M+86.9% | -$34.1M-34,000% | -$7.9M+81.4% | -$27.4M-24.0% | -$330.5M-801% | ||
| -22.7%+132pp | -17%-17.0pp | -3.8%+16.4pp | -13.3%-3.0pp | -155.1%-138pp | ||
| -$0.46+87.1% | -$0.36— | -$0.07+85.1% | -$0.29-20.8% | -$3.57-771% | ||
| -$26.4M+91.6% | -$18.2M-24.7% | $6.9M+129% | -$10.7M-143% | -$315.1M-1,372% | ||
| -13.8%+134pp | -9.1%-1.6pp | 3.3%+14.8pp | -5.2%-3.1pp | -147.9%-138pp | ||
| -$38.9M+88.2% | -$30.7M-5.9% | -$5.7M+85.4% | -$23.3M-16.5% | -$329.2M-802% |
FAQ
- What is Myriad Genetics's revenue?
- Myriad Genetics (MYGN) generated $806.6M in revenue over the trailing twelve months, down 3.2% year over year.
- Is Myriad Genetics profitable?
- Myriad Genetics is not currently profitable: it reported a net loss of $112.6M over the trailing twelve months, a -14.0% net margin.
- What are Myriad Genetics's profit margins?
- Gross margin is 68.8% and operating margin is -12.2%, with a -14.0% net margin.
- What is Myriad Genetics's earnings per share?
- Myriad Genetics's diluted EPS over the trailing twelve months is $-1.18.
- Where does Myriad Genetics's income statement data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
